128 results about "Sodium pyruvate" patented technology

The invention relates to the technical field of microorganisms, and discloses an induction method of VBNC state shigella, a resuscitation medium and application, and the resuscitation medium comprises Rpf recombinant protein, MgSO4, sodium pyruvate, vitamin B12, tryptone, glucose, dipotassium phosphate, monopotassium phosphate, sodium chloride and Tween 80. The resuscitation culture medium obtained by the invention can be used for successfully culturing Shigella in a VBNC state.

The invention discloses a gelatin microcarrier lysate as well as a preparation method and application thereof. The gelatin microcarrier lysis buffer comprises lyase, a cell protective agent, a cell energy metabolism protective agent, an antioxidant, a buffer solution and a chelating agent. The gelatin microcarrier lysate has extremely strong protectiveness to cells, abandons damaging trypsin and EDTA, and innovatively adds a cell protection combination of a cell protective agent L-arginine, a cell energy metabolism protective agent sodium pyruvate and an antioxidant vitamin C, so that the cell survival rate (gt; 98%) and the retention rate (gt; the method is high in cell yield, good in safety and wide in range.

The invention belongs to the technical field of sewage treatment, and particularly relates to a composite carbon source additive and a preparation method thereof. The composite carbon source additive comprises the following components in parts by weight: 30-40 parts of bagasse, 8-12 parts of a polyvinyl alcohol derivative, 2-4 parts of a functional filler, 5-8 parts of potassium citrate and 5-8 parts of sodium pyruvate, the preparation process of the polyvinyl alcohol derivative comprises the following steps: adding polyvinyl alcohol, 1, 3, 5-benzene trisulfonic acid, triethylamine and 4-dimethylaminopyridine into dichloromethane to react, filtering, washing and drying; the polyvinyl alcohol derivative is obtained. The composite carbon source additive can be slowly released in the denitrification process and continuously and stably provide a carbon source, the denitrification process is promoted, and the denitrification efficiency is improved.

The present invention belongs to the field of selective culture of microorganisms and relates to a detection medium for Burkholderia cepacia complex in a pharmaceutical water system. A detection medium for Burkholderia cepacia complex in a pharmaceutical water system, the formula (g / L) of the detection medium is: peptone 0.5 - 2.0 g, sodium pyruvate 1 - 4 g, carbon source 1 - 4 g, yeast extract 0.5 - 2.0 g, casein amino acid 1 - 4 g, magnesium sulfate 0.05 - 0.2 g, and the solvent is water. The inventor has screened a detection medium for Burkholderia cepacia complex in a pharmaceutical water system with special components. Through the culture experiment of Burkholderia cepacia complex, it is found that whether it is a standard strain or a wild strain isolated from a pharmaceutical water system, within the same culture time, the OD 600 value results of 1 / 10 TSB and R2A liquid media do not exceed 0.5, while the bacterial concentration in the detection (BCB) medium for Burkholderia cepacia complex in a pharmaceutical water system is significantly higher than that in 1 / 10 TSB and R2A liquid media.

The present invention belongs to the technical field of rapid detection of drug sensitivity for bacteria. Disclosed are an enrichment culture medium, and a preparation method therefor and the use thereof. The enrichment culture medium comprises the following raw materials in parts by mass: 15.0-20.0 parts of tryptone, 3.5-5.5 parts of peptone, 1.5-3.5 parts of glucose, 5.0-6.5 parts of yeast extract, 2.0-2.5 parts of dipotassium phosphate, 2.0-3.5 parts of disodium hydrogen phosphate, 1.0-1.5 parts of monopotassium phosphate, 2.5-7.5 parts of sodium chloride, 12.0-18.0 parts of proteose peptone, 15.0-22.0 parts of beef heart infusion powder, 8.0-12.0 parts of soya peptone, 1.0-5.0 parts of 0.1% nicotinamide adenine dinucleotide (NAD), 30-100 parts of newborn calf serum inactivated at 56°C for 30 min, 2.0-4.0 parts of mannitol, 3.0-5.0 parts of sodium pyruvate, 0.23-0.45 parts of cycloheximide, 0.8-2.0 parts of 0.05% bromothymol blue, 2.5-4.5 parts of 0.1% methylene blue, and 1000 parts of distilled water, with the pH value of 6.8-7.5. The enrichment culture medium is used to screen effective therapeutic drugs for bacterial diseases in poultry, and is convenient to use and has a single enrichment effect superior to that of respective selective enrichment broths of target bacteria. Therefore, the culture medium can realize rapid proliferation of common pathogenic bacteria in poultry.

The invention belongs to the field of biological medicine, and particularly relates to application of pyruvate in preparation of a medicine for treating lung biofilm infection. According to the application of the pyruvate in preparation of the medicine for treating lung biofilm infection, the pyruvate is a compound I, and the structural formula of the pyruvate is shown in the specification. The pyruvate disclosed by the invention is prepared from sodium pyruvate through chemical modification, has anti-infection activity and biocompatibility, and can be used for remarkably reducing the expression level of inflammatory factors and improving the treatment effect while reducing the dosage of medicines. The pyruvate disclosed by the invention has a wide application prospect in preparation of a medicine for treating lung biofilm infection.

The invention discloses a culture method for hypoxia culture of umbilical cord mesenchymal stem cells, which comprises the following steps: hypoxia pre-adaptive culture: inoculating umbilical cord mesenchymal stem cells in a culture medium containing bFGF (basic fibroblast growth factor), glutathione, astragalus polysaccharide and salidroside, and transferring the umbilical cord mesenchymal stem cells into a 5% O2 environment after the umbilical cord mesenchymal stem cells are preliminarily adhered to the wall in a normal oxygen environment; performing low-oxygen enrichment culture: replacing a second culture medium containing astragalus polysaccharide, salidroside, D-ribose, sodium pyruvate and D-glucose, and promoting efficient cell proliferation under 2% O2; performing function strengthening culture: adding tanshinone IIA and GSK-269962A, inducing cells to secrete VEGF under 1% O2, and maintaining high dryness. According to the method, through the synergistic effect of the three-stage gradient oxygen concentration and the specific serum-free culture medium, the cell proliferation multiple is remarkably increased, the total apoptosis rate is reduced, VEGF secretion is promoted, the multidirectional differentiation potential is reserved, the culture method is standardized in operation, the serum-free culture medium is definite in component, and a high-quality stem cell culture scheme is provided for the field of regenerative medicine.

The invention discloses an umbilical cord mesenchymal stem cell serum-free culture medium, which is composed of a basic culture medium and additive components, and the additive components comprise, by final concentration, 5-20 [mu] g / mL of astragalus polysaccharide, 0.5-2.0 [mu] g / mL of salidroside, 0.1-0.5 [mu] g / mL of tanshinone IIA, 0.1-0.3 mg / mL of sodium pyruvate, 5-15 mM of D-ribose, 3-6 mg / mL of recombinant human albumin, and 5-10 [mu] g / mL of recombinant transferrin; the invention also discloses a method for culturing umbilical cord mesenchymal stem cells under the hypoxia condition by using the serum-free culture medium. The method comprises the steps of cell inoculation, culture under the hypoxia condition, subculture, cell passage and the like. The astragalus polysaccharide, the salidroside, the tanshinone IIA, the sodium pyruvate, the recombinant human albumin and the recombinant transferrin are added into the serum-free culture medium, so that nutrition supply and function maintenance of cells under a low-oxygen condition are guaranteed, the proliferation rate and the differentiation capacity of the cultured cells are improved, the apoptosis rate of the cells is reduced, and the survival rate of the cells is increased. Wide application prospects are realized in the fields of cell culture, regenerative medicine and the like.

The application provides a culture medium and a culture method of ovarian cancer primary cells. The culture medium comprises an MST1 / 2 kinase inhibitor, sodium pyruvate, forskolin, epidermal growth factor, gastrin, fibroblast growth factor 7, nicotinamide, SB431542, and fetal bovine serum. Compared with the existing culture method, the in-vitro culture using the culture medium of the application has higher amplification efficiency; the culture of the ovarian cancer primary cells using the culture medium can maintain the morphological structure and pathological characteristics of the primary tissue, and improve the success rate and survival rate of the ovarian cancer primary cell culture.

Provided herein is a method for reducing a lactate spike and increasing titer in a fed-batch process for producing a protein of interest, comprising reducing pyruvate (e.g., sodium pyruvate) concentration in one or more feeds to cells in a bioreactor in the fed-batch process.

The present invention belongs to the field of cell culture and preservation, and specifically discloses a serum-free and DMSO-free mesenchymal stem cell cryopreservation solution, its preparation method and application. The cryopreservation solution contains the following components: a basic diluent 40-80 v / v%, a permeable cryoprotectant 5-20 v / v%, a non-permeable cryoprotectant 1-10 v / v%, a cell membrane protectant 5-20 v / v%, a cell activity additive 5-20 v / v%, and a plant-derived natural antioxidant composition; the basic diluent contains the following components: sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium hydrogen phosphate, sodium bicarbonate, D-glucose, HEPES, and sodium pyruvate; the plant-derived natural antioxidant composition is cyanidin-3-O-glucoside C3G and epigallocatechin gallate EGCG; this cryopreservation solution does not contain serum or DMSO, and creatively combines the two plant-derived natural antioxidants C3G and EGCG. The sources and dosages of all components are clear, it does not contain any cytotoxic components, is easy to use, has a high cell recovery viability after cryopreservation, and has a wide range of applications.

The application discloses a chromogenic culture medium for detecting enteropathogenic Escherichia coli, which contains peptone, sodium pyruvate, sodium chloride, D-sorbitol, D-malic acid, bile salt, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, sodium hydroxide, kaolin, bromothymol blue, crystal violet, polyethylene glycol and agar, and the rest is water. The chromogenic culture medium is simple in composition, convenient to prepare and use, and can be used for identifying enteropathogenic Escherichia coli EPEC according to the color of bacterial colonies, and has the advantages of specificity, high efficiency, rapidness, low cost, simple result judgment and the like, and has a wide application prospect in food safety monitoring.

The invention discloses a black soil prokaryote separation culture medium as well as a preparation method and application thereof. The isolation medium is prepared from a solution A, a solution B and a solution C, wherein the solution A comprises a nitrogen source, glucose, soluble starch and sodium pyruvate; the solution B comprises the following components: nitrilotriacetic acid and inorganic salt; the solution C comprises the following components: vitamins, lipoic acid and para aminobenzoic acid. The separation culture medium is designed and developed based on a complex microbial community structure in black soil, the nutrient concentration of the separation culture medium is low, compared with a conventional culture medium, prokaryotes separated by the separation culture medium are more in variety and better in effect, and the separation culture medium has important value and significance in development and utilization of black soil microbial resources.

The invention discloses a system for directionally differentiating chicken primordial germ cells into gametes in vitro and a regulation and control method, the system comprises a basic culture medium: based on DMEM / F12, adding 10% of fetal calf serum, 2% of chicken serum, 2 mmol / L of L-glutamine, 1 mmol / L of sodium pyruvate and 5.5 * 10 <-5 > mol / L of beta-mercaptoethanol; the spermatogonium induction culture medium further comprises BMP4, RA and GDNF; the oogonium induction culture medium also comprises BMP15, GDF9 and EGF (Epidermal Growth Factor). According to the system and the regulation and control method, the differentiation efficiency is improved, the culture period is shortened, and the number of cell clusters is remarkably increased.

The invention provides a THP-1 mononuclear cell culture medium and a culture method thereof. The THP-1 mononuclear cell culture medium comprises the following components: a complete culture medium, 8v / v%-12v / v% of fetal calf serum, 20mM-30mM of HEPES, 0.8 mM-1.2 mM of sodium pyruvate and 0.8 v / v%-1.2 v / v% of antibiotics. Wherein the HEPES is 2-4M HEPES mother liquor prepared by using a complete culture medium, the sodium pyruvate is 2-4M sodium pyruvate mother liquor prepared by using a complete culture medium, the complete culture medium is an RPMI 1640 culture medium, and the antibiotic is mycillin. The invention provides a series of optimized processes of a THP-1 cell culture method, passage, culture medium and the like, so that the THP-1 cell culture method is improved, the resuscitation state of the cryopreserved THP-1 cells is improved, and the phenomena of cell death and the like are reduced; besides, the THP-1 cell culture medium provided by the invention is optimized in formula and scientific in proportioning, the sensitivity degree of THP-1 cells to serum quality is reduced, and the good growth state of the THP-1 cells is further improved.

The invention relates to an establishment method and application of a micropterus salmoides muscle cell line, and belongs to the technical field of cell culture. The invention provides a culture solution which takes an M199 culture medium as a basic culture medium and further comprises sodium pyruvate, hydroxyethyl piperazine ethanesulfonic acid, beta-mercaptoethanol, penicillin, streptomycin and fetal calf serum. The culture solution provides optimal conditions for micropterus salmoides muscle cell culture, the culture cost is also reduced, the micropterus salmoides muscle cell line is established by adopting the culture solution, the method is simple and easy to operate and high in repeatability, the established cell line is good in stability, continuous passage and ultralow-temperature cryopreservation can be realized, the cell division speed is high, the passage time is short, the adherence rate is high, and the method is suitable for large-scale popularization and application. In the method, the micropterus salmoides muscle primary cell culture time is short, the number of obtained cells is large, the activity is good, and passage can be carried out in only 8 days.

The invention relates to the technical field of NK cell culture, and discloses an NK culture medium containing hypotaurine and application of the NK culture medium to improvement of NK cell proliferation and killing activity, and the NK culture medium comprises a basic NK cell culture medium and hypotaurine; the basic NK cell culture medium does not contain hypotaurine and comprises amino acid, vitamins, inorganic salt, trace elements, D-glucose and sodium pyruvate. When the basic NK cell culture medium is an RPMI1640 culture medium, the concentration of the hypotaurine is 0.1-1 mM; when the basic NK cell culture medium is an IMDM culture medium, the concentration of the hypotaurine is 0.4-4 mM. According to the scheme, the hypotaurine is added into the basic NK cell culture medium to obtain the NK culture medium, the NK culture medium can increase the number of NK cells when the NK cells are cultured in vitro, and the killing activity of the cultured NK cells on tumor cells is remarkably improved.

This invention discloses an in vitro maturation culture medium for ferret oocytes and its preparation method, belonging to the field of animal embryo engineering technology. It comprises the following components: TCM199 basal culture medium, 50 mL fetal bovine serum, 25 IU follicle-stimulating hormone, 25 IU luteinizing hormone, 0.5 mg 17β-estradiol, 0.005 mg epidermal growth factor, 12.1 mg sodium pyruvate, 0.2 mM cysteine, 0.1 mM cysteine, 0.030 g penicillin, 0.025 g streptomycin sulfate, as well as an antioxidant complex, a combination of growth factors, and extracellular matrix components. This invention provides a comprehensive and suitable nutritional environment for ferret oocytes by precisely formulating a composite culture medium containing multiple key components. Specifically, the hormone combination at specific concentrations accurately simulates the in vivo physiological environment, effectively regulating the oocyte maturation process; multiple growth factors work synergistically to promote oocyte growth, development, and differentiation; and the addition of the antioxidant complex effectively eliminates free radicals generated during in vitro culture, reducing oxidative stress damage to oocytes.

A kit for in-vitro extraction of cell mitochondria and a method. The kit comprises an extraction liquid A, an extraction liquid B, an extraction liquid C and a preservation liquid, the extraction liquid A comprising EDTA, sodium lactate and sodium chloride, the extraction liquid B being a heparin solution, the extraction liquid C comprising mannitol, EDTA, sodium lactate and sodium chloride, and the preservation liquid comprising mannitol, EDTA, sodium lactate, succinic acid, sodium pyruvate and sodium chloride. Using the extraction liquids and the preservation liquid can better maintain the functions of mitochondria in vitro, thus prolonging the time span from extracting mitochondria to applying same to the bodies of patients, and helping to clinical application of mitochondrial transplantation.

The present invention belongs to the field of biomedical technologies, and particularly relates to the application of pyruvate in the preparation of a drug for enhancing the efficacy of lung cancer chemotherapy. The present invention provides a novel drug for treating lung cancer, namely Compound I obtained by structurally modifying sodium pyruvate. Experimental results show that this compound can significantly inhibit the proliferation of lung cancer cells A549 in mice, and at the same time has an inhibitory effect on the growth of human lung cancer A549 cell xenografts in nude mice, expanding the therapeutic potential of existing drugs and providing new treatment options for lung cancer patients. Its high efficiency in treating lung cancer is of great significance in improving the treatment effect and reducing the burden on patients.

The invention relates to the technical field of cell culture, in particular to an efficient separation culture method for hepatocytes of small yellow croakers and a hepatocyte source identification method. The invention provides a method for efficiently separating and culturing hepatocytes of small yellow croakers, which comprises the following steps: selecting liver tissues of juvenile small yellow croakers, cleaning with a PBS (Phosphate Buffer Solution) containing high-concentration double antibodies, and digesting with pancreatin to quickly obtain hepatocytes; optimizing cell culture to obtain an L-15 culture medium containing 10% of FBS, 1% of sodium pyruvate and 0.2% of NaCl; and cell source identification is carried out by amplifying mitochondrial COI gene and 16S rRNA gene sequences. According to the method, the separation efficiency of the hepatocytes of the small yellow croakers is remarkably improved, the pollution rate is reduced, the result reliability is improved through double-gene molecular identification, the technical blank of construction of hepatocyte lines of the small yellow croakers is filled, and the method has wide application potential in the fields of aquaculture, fish physiology research, environmental toxicology detection and the like.

This invention belongs to the fields of applied environmental microbiology and agricultural biotechnology, and discloses ImALS, an acetyllactone synthase resistant to high concentrations of methoxylamine, its encoding gene, and its applications. Its nucleotide sequence is SEQ ID NO.1, with a full length of 1785 bp, encoding 594 amino acids, and its amino acid sequence is SEQ ID NO.2. ImALS shares less than 58.3% homology with previously reported acetyllactone synthases, thus representing a novel ALS gene. The acetyllactone synthase ImALS provided by this invention exhibits a specific activity of 0.52 mM / mg against sodium pyruvate. ImALS demonstrates strong resistance to the ALS inhibitor methoxylamine herbicide, with a half-maximal inhibitory concentration (IC50) of 1500 μM, indicating that the ImALS gene has significant application potential in methoxylamine-resistant transgenic engineering.

A micronutrient composition comprises of several combinations of individual ingredients in forming Mix 11, G12, G13 and core mix formulation. Core mix contains magnesium citrate, alpha-Ketoglutaric acid, L-Citrulline and Taurine. The Mix 11, G12 and G13 contains Magnesium Citrate, Alpha-Ketoglutaric Acid, Niacinamide, L-Glutamine, L-Citrulline, Sodium Pyruvate, Succinic acid, Vitamin B complex, Taurine, L-Cysteine, L-Methionine, L-Ascorbic Acid, Coenzyme Q10 or combination thereof. A method of administering and treating a specific disease which is due to one of an oxidative stress, impaired mitobiogenesis and ATP production in a mammal is disclosed.

The present application relates to the field of aquaculture technology, and particularly relates to a culture method of bigmouth bass gill explants and application. The present application provides a culture method of bigmouth bass gill explants, which uses explant culture solution to culture the gill explants of bigmouth bass. The explant culture solution is formed by adding fetal bovine serum, fish serum, trinity, D-galactose, L-alanyl-L-glutamine, sodium pyruvate and melatonin into a basic culture medium. In combination with dynamic culture conditions, the natural three-dimensional structure and intercellular connection of the gill tissue can be preserved, and the metabolic activity and functional integrity thereof can be maintained. The present application can solve the technical problem that the prior art cannot provide an ideal research model which can both maintain the structural integrity of the gill tissue and accurately reflect the functional characteristics of the gill tissue. Through the culture method, research models such as ammonia nitrogen stress can be efficiently constructed, thereby providing technical support for the research of bigmouth bass gill tissue physiological mechanism, disease prevention and control, environmental risk assessment and the like.

The invention discloses an efficient mouse small intestine epithelial cell isolated culture method. The method comprises the steps of fetal mouse small intestine tissue obtaining, flushing digestion, sediment obtaining through centrifugal separation, density gradient centrifugal purification, differential adhesion method purification, inoculated culture and culture medium replacement for further culture. During culture, a first culture medium and a second culture medium based on William's E basic culture media are sequentially used, and the first culture medium comprises fetal calf serum, EGF, L-glutamine, mannitol, methylprednisone, bovine insulin and double antibodies; the second culture medium is prepared from fetal calf serum, vitamin C, L-glutamine, resveratrol, sodium pyruvate, bovine insulin and double antibodies. The rapid adherent proliferation and long-term stable culture of the mouse small intestine epithelial cells on the 2D surface are realized through mutual cooperation of the two culture media, so that the separation and in-vitro culture method of the mouse small intestine epithelial cells, which is simple, easy to operate, stable and efficient, is established, and convenience is provided for metabolic research of various in-vitro drugs and inflammatory factors.

Enrichment media useful for the repair and growth of gram-negative bacteria are described herein. The enrichment medium may include pyruvic acid (e.g., sodium pyruvate), magnesium (e.g., magnesium sulfate), yeast extract, and a selectivity agent that inhibits the growth of gram-positive bacteria.

The present application belongs to the technical field of sewage treatment, and particularly relates to a composite carbon source additive and a preparation method thereof. The composite carbon source additive comprises the following components in parts by weight: 30-40 parts of sugarcane residue, 8-12 parts of polyvinyl alcohol derivative, 2-4 parts of functional filler, 5-8 parts of potassium citrate and 5-8 parts of sodium pyruvate. The preparation process of the polyvinyl alcohol derivative is as follows: polyvinyl alcohol, 1,3,5-benzene trisulfonic acid, triethylamine and 4-dimethylaminopyridine are added into dichloromethane for reaction, and then filtration, washing and drying are performed to obtain the polyvinyl alcohol derivative. The composite carbon source additive can slowly release and continuously and stably provide carbon source in the denitrification process, promote the denitrification process and improve the denitrification efficiency.

The present invention provides the use of pyruvate in the treatment of lipodystrophy syndrome, belonging to the technical field of endocrine and metabolic disease treatment. This invention proposes for the first time the use of pyruvate, such as sodium pyruvate and potassium pyruvate, in the treatment of lipodystrophy syndrome. It has been found that pyruvate can restore atrophic adipose tissue and improve the progression of diabetic complications and acute pancreatitis associated with hypertriglyceridemia, thereby increasing patient survival and improving overall prognosis.

A culture medium and a culture method for constructing prostate cancer organoids are provided. The culture medium includes a basic culture medium, and the following components with final concentrations: R-spondin1 15-200 ng / mL, Noggin 20-150 ng / mL, FGF2 5-15 ng / mL, FGF10 1-10 ng / mL, CHIR99021 0.5-1 μM, ALK inhibitor 0.25-1 μM, ROCK inhibitor 5-30 μM, nicotinamide 5-10 mM and sodium pyruvate 0.5-3 mM. The present culture medium and culture method can effectively improve the survival rate and formation efficiency of organoids through the compounding of each component.

The invention belongs to the technical field of biology, and particularly relates to an additive composition for CHO cell culture and application of the additive composition. The composition is prepared from 0.1 g / L to 0.5 g / L of carboxymethyl-beta-cyclodextrin, 0.4 g / L to 1.2 g / L of asparagine and 0.02 g / L to 0.1 g / L of sodium pyruvate. By adding the composition, the antibody yield can be effectively increased, meanwhile, the glycosylation modification proportion of G0F is increased, and a simple, convenient and effective yield and quality control method is provided for research, development and production of antibody drugs.